• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Waystar Reports Fourth Quarter and Fiscal Year 2025 Results, Provides 2026 Guidance

    2/17/26 7:00:00 AM ET
    $WAY
    EDP Services
    Technology
    Get the next $WAY alert in real time by email

    Q4 revenue of $304M, up 24% YoY

    Q4 net income of $20.0M and non-GAAP net income of $70.7M

    Q4 net income margin of 7%; adjusted EBITDA margin of 43%

    FY 2025 revenue of $1,099M, up 17% YoY

    FY net income of $112.1M and non-GAAP net income of $262.9M

    FY net income margin of 10%; adjusted EBITDA margin of 42%

    LEHI, Utah and LOUISVILLE, Ky., Feb. 17, 2026 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, today reported results for the fourth quarter and full year ended December 31, 2025.

    Waystar's logo (PRNewsfoto/Waystar)

    "Waystar is delivering strong growth and momentum—driving record bookings, integrating the Iodine acquisition ahead of plan, and accelerating AI-powered innovation across our platform," said Matt Hawkins, Chief Executive Officer of Waystar. "We are leading healthcare's AI transformation by advancing the autonomous revenue cycle, leveraging unmatched proprietary data and deep domain expertise to deliver meaningful outcomes for providers. Our 2026 guidance reflects a robust pipeline, accelerating demand for an end-to-end AI-powered platform, and disciplined execution to sustain durable, profitable growth."

    Fourth Quarter 2025 Financial Highlights

    • Revenue of $303.5 million, up 24% year-over-year
    • Net income of $20.0 million, GAAP net income per diluted share of $0.10, and net income margin of 7%
    • Non-GAAP net income of $70.7 million and non-GAAP net income per diluted share of $0.36
    • Adjusted EBITDA of $129.1 million and adjusted EBITDA margin of 43%
    • Cash flow from operations of $67 million and unlevered free cash flow of $80 million

    Fiscal Year 2025 Financial Highlights

    • Revenue of $1,099.3 million, up 17% year-over-year
    • Net income of $112.1 million, GAAP net income per diluted share of $0.61, and net income margin of 10%
    • Non-GAAP net income of $262.9 million and non-GAAP net income per diluted share of $1.42
    • Adjusted EBITDA of $462.1 million and adjusted EBITDA margin of 42%
    • Cash flow from operations of $310 million and unlevered free cash flow of $365 million

    Key Performance Metrics and Revenue Disaggregation

    • 1,391 clients contributed over $100,000 in LTM revenue, up 16% year-over-year
    • Net revenue retention rate (NRR) of 112%
    • Fourth quarter 2025 subscription revenue of $167.8 million, up 38% year-over-year
    • Fourth quarter 2025 volume-based revenue of $134.2 million, up 11% year-over-year
    • Fiscal year 2025 subscription revenue of $558.4 million, up 22% year-over-year
    • Fiscal year 2025 volume-based revenue of $534.8 million, up 11% year-over-year

    Financial Outlook

    As of February 17, 2026, Waystar provides the following guidance for its full fiscal year 2026.1

    • Total revenue is expected to be between $1.274 billion and $1.294 billion
    • Adjusted EBITDA is expected to be between $530 million and $540 million
    • Non-GAAP net income is expected to be between $317 million and $335 million
    • Diluted non-GAAP net income per share is expected to be between $1.59 and $1.68

    Webcast Information

    Waystar's financial results will be discussed on a conference call scheduled at 8:30 a.m.  Eastern Standard Time today, February 17, 2026. A live audio conference call will be available on Waystar's website at https://investors.waystar.com/news-events/events. The webcast will be archived on the site for those unable to listen in real time. This earnings release and the related Current Report on Form 8-K filed February 17, 2026, are available on the Investor Relations page of the company's website. We routinely post important information on our website, including corporate and investor presentations and financial information. We intend to use our website as a means of disclosing material, non-public information and for complying with our disclosure obligations under Regulation FD. Such disclosures will be included in the Investor Relations section of our website. Accordingly, investors should monitor this portion of our website, in addition to following our press releases, U.S. Securities and Exchange Commission ("SEC") filings, and public conference calls and webcasts.

    Non-GAAP Financial Measures

    To supplement the consolidated financial statements prepared and presented in accordance with U.S. generally accepted accounting principles ("GAAP"), this press release contains certain non-GAAP financial measures as defined below. We present non-GAAP financial measures as supplemental measures of financial performance that are not required by, or presented in accordance with, GAAP. We believe they assist investors and analysts in comparing our operating performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. Management believes these non-GAAP financial measures are useful to investors in highlighting trends in our operating performance, while other measures can differ significantly depending on long-term strategic decisions regarding capital structure, the tax jurisdictions in which we operate, and capital investments. Management uses adjusted EBITDA and adjusted EBITDA margin to supplement GAAP measures of performance in the evaluation of the effectiveness of our business strategies, to make budgeting decisions, to establish discretionary annual incentive compensation, and to compare our performance against that of other peer companies using similar measures. Management supplements GAAP results with non-GAAP financial measures to provide a more complete understanding of the factors and trends affecting the business than GAAP results alone provide.

    Adjusted EBITDA, adjusted EBITDA margin, non-GAAP net income, non-GAAP net income per share and unlevered free cash flow are not recognized terms under GAAP and should not be considered as an alternative to net income (loss) or net income (loss) margin as measures of financial performance or cash provided by operating activities as a measure of liquidity, or any other performance measure derived in accordance with GAAP. Additionally, these measures are not intended to be a measure of free cash flow available for management's discretionary use, as they do not consider certain cash requirements such as interest payments, tax payments, and debt service requirements. The presentations of these measures have limitations as analytical tools and should not be considered in isolation, or as a substitute for analysis of our results as reported under GAAP. Because not all companies use identical calculations, the presentations of these measures may not be comparable to other similarly titled measures of other companies and can differ significantly from company to company. A reconciliation is provided below for our non-GAAP financial measures to the most directly comparable financial measure stated in accordance with GAAP. Investors are encouraged to review the related GAAP financial measures and the reconciliation of non-GAAP financial measures to their most directly comparable GAAP financial measures, and not to rely on any single financial measure to evaluate our business.

    The following non-GAAP financial measures and key performance metrics are defined below:

    Adjusted EBITDA and adjusted EBITDA Margin

    We define adjusted EBITDA as net income / (loss) before interest expense, net, income tax expense / (benefit), depreciation and amortization, and as further adjusted for stock-based compensation expense, acquisition and integration costs, asset and lease impairments, costs related to amended debt agreements and IPO and secondary offering costs. Adjusted EBITDA margin represents adjusted EBITDA as a percentage of revenue.

    Non-GAAP Net Income / (loss) and Non-GAAP Net Income / (loss) Per Share

    We define non-GAAP net income as GAAP net income / (loss) excluding the impact of stock-based compensation, acquisition and integration costs, asset and lease impairments, costs related to our IPO, and the Secondary Offerings, and costs related to amended debt agreements and amortization of intangibles. The tax effects of the adjustments are calculated using a management estimated annual effective non-GAAP tax rate of 21%, which is based on our statutory federal tax rate and provides consistency across interim reporting periods by eliminating the effects of non-recurring and period specific items. Due to the differences in the tax treatment of items excluded from non-GAAP net income, our estimate tax rate on non-GAAP net income may differ from our GAAP tax rate. Non-GAAP net income per share is shown on both a basic and diluted basis and is defined as non-GAAP net income divided by the basic or diluted weighted-average shares, respectively.

    Unlevered Free Cash Flow

    We define unlevered free cash flow as cash from operations plus cash interest paid less capital expenses.

    Net Debt

    We define net debt as the sum of the current portion of long-term debt, long-term debt, and accounts receivable securitization less cash and equivalents and investment securities.

    Adjusted Net Leverage Ratio

    We define adjusted net leverage ratio as net debt divided by adjusted EBITDA over the preceding twelve months.

    Key Performance Metrics

    Net Revenue Retention Rate

    Our Net Revenue Retention Rate compares twelve months of client invoices for our solutions at two period end dates. To calculate our Net Revenue Retention Rate, we first accumulate the total amount invoiced during the twelve months ending with the prior period-end or Prior Period Invoices. We then calculate the total amount invoiced to those same clients for the twelve months ending with the current period-end, or Current Period Invoices. Current Period Invoices are inclusive of upsell, downsell, pricing changes, clients that cancel or chose not to renew, and discontinued solutions with continuing clients. The Net Revenue Retention Rate is then calculated by dividing the Current Period Invoices by the Prior Period Invoices. Our total invoices included in the analysis are greater than 98% of reported revenue. We use Net Revenue Retention Rate to evaluate our ongoing operations and for internal planning and forecasting purposes. Acquired businesses are included in the last-twelve-month Net Revenue Retention Rate in the ninth quarter after acquisition, which is the earliest point that comparable post-acquisition invoices are available for both the current and prior twelve-month period.

    Customer Count with >$100,000 of Revenue

    We regularly monitor and review our count of clients who generate more than $100,000 of revenue.

    Our count of clients who generate more than $100,000 of revenue is based on an accumulation of the amounts invoiced to clients over the preceding twelve months. The invoices for acquired clients are included starting in the first full calendar quarter after the date of acquisition.

    Forward-Looking Statements

    This press release contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that reflect our current views with respect to, among other things, statements regarding Waystar's expectations relating to future operating results and financial position, including full year 2026, and future periods; the performance of our new product offerings; our industry and market opportunities, business strategy, goals, and expectations concerning our market position, future operations, margins and profitability, capital expenditures, liquidity, and capital resources and other financial and operating information. Forward-looking statements include all statements that are not historical facts. These statements may include words such as "anticipate," "assume," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "future," "will," "seek," "foreseeable," "outlook," the negative version of these words or similar terms and phrases to identify forward-looking statements in this press release, including the discussion of outlook for full fiscal year 2026.

    The forward-looking statements contained in this press release are based on management's current expectations and are not guarantees of future performance. The forward-looking statements are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. Our expectations, beliefs, and projections are expressed in good faith, and we believe there is a reasonable basis for them. However, there can be no assurance that management's expectations, beliefs, and projections will result or be achieved. The following factors are among those that may cause actual results to differ materially from the forward-looking statements: our operation in a highly competitive industry; our ability to retain our existing clients and attract new clients; our ability to successfully execute on our business strategies in order to grow; our ability to accurately assess the risks related to acquisitions and successfully integrate acquired businesses, including the acquisition of Iodine; our ability to establish and maintain strategic relationships; the growth and success of our clients and overall healthcare transaction volumes; consolidation in the healthcare industry; our selling cycle of variable length to secure new client agreements; our implementation cycle that is dependent on our clients' timing and resources; our dependence on our senior management team and certain key employees, and our ability to attract and retain highly skilled employees; the accuracy of the estimates and assumptions we use to determine the size of our total addressable market; our ability to develop and market new solutions, or enhance our existing solutions, to respond to technological changes or evolving industry standards; the interoperability, connectivity, and integration of our solutions with our clients' and their vendors' networks and infrastructures; the performance and reliability of internet, mobile, and other infrastructure; the consequences if we cannot obtain, process, use, disclose, or distribute the highly regulated data we require to provide our solutions; our reliance on certain third-party vendors and providers; any errors or malfunctions in our products and solutions; failure by our clients to obtain proper permissions or provide us with accurate and appropriate information; the potential for embezzlement, identity theft, or other similar illegal behavior by our employees or vendors, and a failure of our employees or vendors to observe quality standards or adhere to environmental, social, and governance standards; our compliance with the applicable rules of the National Automated Clearing House Association and the applicable requirements of card networks; increases in card network fees and other changes to fee arrangements; the effect of payer and provider conduct which we cannot control; privacy concerns and security breaches or incidents relating to our platform or data (including personal information and other regulated data); the complex and evolving laws and regulations regarding privacy, data protection, and cybersecurity; our ability to adequately protect and enforce our intellectual property rights; our ability to use or license data and integrate third-party technologies; the development, deployment, and use of AI; our use of "open source" software; legal proceedings initiated by third parties alleging that we are infringing or otherwise violating their intellectual property rights; claims that our employees, consultants, or independent contractors have wrongfully used or disclosed confidential information of third parties; the heavily regulated industry in which we conduct business; the uncertain and evolving healthcare regulatory and political framework; health care laws and data privacy and security laws and regulations governing our Processing of personal information (which may also be referred to as "personal data" or "personally identifiable information"); reduced revenues in response to changes to the healthcare regulatory landscape; legal, regulatory, and other proceedings that could result in adverse outcomes; contractual obligations requiring compliance with certain provisions of the Bank Secrecy Act/anti-money laundering laws and regulations; existing laws that regulate our ability to engage in certain marketing activities; our full compliance with website accessibility standards; any changes in our tax rates, the adoption of new tax legislation, or exposure to additional tax liabilities; limitations on our ability to use our net operating losses to offset future taxable income; losses due to asset impairment charges; our substantial debt and restrictive covenants in the agreements governing our Credit Facilities; interest rate fluctuations; unavailability of additional capital on acceptable terms or at all; the impact of general macroeconomic conditions; our history of net losses and our ability to achieve or maintain profitability; the interests of the certain investors may be different than the interests of other holders of our securities; and; and each of the other factors discussed under the heading of "Risk Factors" in the Company's 10K filed with the Securities and Exchange Commission (the "SEC") on February 17, 2026, and in other reports filed with the SEC, all of which are available on the Investor Relations page of our website at investors.waystar.com.

    Any forward-looking statements made by us in this press release speak only as of the date of this press release and are expressly qualified in their entirety by the cautionary statements included in this press release. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. You should not place undue reliance on our forward-looking statements. We undertake no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments, or otherwise, except as may be required by any applicable securities laws.

    About Waystar

    Waystar's mission-critical software is purpose-built to simplify healthcare payments so providers can prioritize patient care and optimize their financial performance. Waystar serves approximately 30,000 clients, representing over 1 million distinct providers, including 16 of 20 institutions on the U.S. News Best Hospitals list. Waystar's enterprise-grade platform annually processes over 7.5 billion healthcare payment transactions, including over $2.4 trillion in annual gross claims and spanning approximately 60% of U.S. patients. Waystar strives to transform healthcare payments so providers can focus on what matters most: their patients and communities. Discover the way forward at waystar.com.

    ________________________

    1We have not reconciled the forward-looking adjusted EBITDA, non-GAAP net income, and non-GAAP net income per share guidance included above to the most directly comparable GAAP measure because this cannot be done without unreasonable effort due to the variability and low visibility with respect to certain costs, the most significant of which are incentive compensation (including stock-based compensation), transaction-related expenses, and certain fair value measurements, which are potential adjustments to future earnings. We expect the variability of these items to have a potentially unpredictable, and a potentially significant, impact on our future GAAP financial results.

     

    Waystar Holding Corp.

    Unaudited Consolidated Statements of Operations

    (in thousands, except for share and per share data)











    Three months ended

    December 31,



    Twelve months ended

    December 31,



    2025



    2024



    2025



    2024

    Revenue

    303,538



    244,102



    1,099,278



    943,549

    Operating expenses















    Cost of revenue (exclusive of depreciation and amortization expenses)

    92,637



    79,542



    348,162



    315,730

    Sales and marketing

    49,212



    38,990



    178,017



    156,935

    General and administrative

    43,709



    22,959



    128,623



    111,753

    Research and development

    18,520



    11,472



    54,623



    48,775

    Depreciation and amortization

    40,442



    37,996



    140,548



    186,631

    Total operating expenses

    244,520



    190,959



    849,973



    819,824

    Income from operations

    59,018



    53,143



    249,305



    123,725

    Other expense















    Interest expense

    (21,868)



    (19,003)



    (74,063)



    (141,762)

    Related party interest expense

    (1,004)



    (1,083)



    (3,479)



    (4,508)

    Income/(loss) before income taxes

    36,146



    33,057



    171,763



    (22,545)

    Income tax expense/(benefit)

    16,158



    13,978



    59,674



    (3,420)

    Net income/(loss)

    19,988



    19,079



    112,089



    (19,125)

    Net income/(loss) per share:















    Basic

    0.10



    0.11



    0.63



    (0.13)

    Diluted

    0.10



    0.11



    0.61



    (0.13)

    Weighted-average shares outstanding:















    Basic

    191,394,748



    172,526,776



    177,926,745



    149,915,839

    Diluted

    197,336,164



    179,112,559



    184,783,285



    149,915,839

     

    Waystar Holding Corp.

    Consolidated Balance Sheets

    (in thousands, except for share and per share data)











    December 31,

    2025



    December 31,

    2024









    Assets







    Current assets







    Cash and cash equivalents

    $       61,355



    $         182,133

    Restricted cash

    15,454



    22,449

    Investment securities

    24,877



    —

    Accounts receivable, net of allowance of $6,170 at December 31, 2025

    and $5,885 at December 31, 2024

    177,037



    145,235

    Income tax receivable

    6,437



    2,838

    Prepaid expenses

    20,078



    14,414

    Other current assets

    3,174



    3,972

    Total current assets

    308,412



    371,041

    Property, plant and equipment, net

    51,649



    46,731

    Operating lease right-of-use assets, net

    12,972



    10,820

    Intangible assets, net

    1,292,839



    1,039,049

    Goodwill

    4,016,818



    3,019,999

    Deferred costs

    93,951



    82,815

    Other long-term assets

    8,459



    6,549

    Total assets

    $    5,785,100



    $       4,577,004

    Liabilities and stockholders' equity







    Current liabilities







    Accounts payable

    $      50,949



    $         47,365

    Accrued compensation

    40,942



    31,589

    Aggregated funds payable

    15,104



    22,059

    Other accrued expenses

    22,990



    15,930

    Deferred revenue

    67,855



    10,527

    Current portion of long-term debt

    13,537



    11,311

    Related party current portion of long-term debt

    657



    357

    Current portion of operating lease liabilities

    6,029



    5,591

    Current portion of finance lease liabilities

    —



    904

    Total current liabilities

    218,063



    145,633

    Long-term liabilities







    Deferred tax liability

    211,320



    100,523

    Long-term debt, net, less current portion

    1,394,523



    1,185,411

    Related party long-term debt, net, less current portion

    64,186



    35,211

    Operating lease liabilities, net of current portion

    11,994



    13,133

    Finance lease liabilities, net of current portion

    —



    11,290

    Deferred revenue - long-term

    5,496



    5,739

    Other long-term liabilities

    692



    278

    Total liabilities

    1,906,274



    1,497,218

    Commitments and contingencies (Note 19)







    Stockholders' equity







    Preferred stock $0.01 par value - 100,000,000 shares authorized as of

      December 31, 2025 and December 31, 2024, respectively; zero shares issued or

      outstanding as of December 31, 2025 and December 31, 2024, respectively

    —



    —

    Common stock $0.01 par value - 2,500,000,000 shares authorized at

      December 31, 2025 and December 31, 2024, respectively; 191,587,193 and

      172,108,240 shares issued and outstanding at December 31, 2025 and

      December 31, 2024, respectively

    1,916



    1,722

    Additional paid-in capital

    3,986,353



    3,298,083

    Accumulated other comprehensive income (loss)

    (632)



    881

    Accumulated deficit

    (108,811)



    (220,900)

    Total stockholders' equity

    3,878,826



    3,079,786

    Total liabilities and stockholders' equity

    $    5,785,100



    $       4,577,004

     

    Waystar

    Consolidated Statements of Cash Flows

    (in thousands)







    Year ended December 31,



    2025



    2024

    Cash flows from operating activities







    Net income/(loss)

    $       112,089



    $       (19,125)

    Adjustments to reconcile net income/(loss) to net cash provided by operating

        activities







    Depreciation and amortization

    140,548



    186,631

    Stock-based compensation

    42,069



    54,437

    Provision for bad debt expense

    3,320



    2,669

    Loss on extinguishment of debt

    821



    20,611

    Loss on lease termination

    838



    —

    Deferred income taxes

    45,222



    (59,135)

    Amortization of debt discount and issuance costs

    2,697



    3,946

    Other

    154



    (99)

    Changes in:







    Accounts receivable

    (7,324)



    (21,816)

    Income tax refundable

    (16,993)



    3,973

    Prepaid expenses and other current assets

    (1,947)



    (2,322)

    Deferred costs

    (10,866)



    (16,497)

    Other long-term assets

    (2,376)



    (472)

    Accounts payable and accrued expenses

    8,932



    18,228

    Deferred revenue

    (4,658)



    (842)

    Operating lease right-of-use assets and lease liabilities

    (2,853)



    (419)

    Net cash provided by operating activities

    309,673



    169,768

    Cash flows from investing activities







    Purchase of property and equipment and capitalization of internally developed

       software costs

    (26,481)



    (27,268)

    Acquisitions, net of cash and cash equivalents acquired

    (629,535)



    —

    Purchase of investment securities

    (231,324)



    —

    Proceeds from sale of investment securities

    206,444



    —

    Net cash used in investing activities

    (680,896)



    (27,268)

    Cash flows from financing activities







    Change in aggregated funds liability

    (6,955)



    12,399

    Proceeds from equity offering, net of underwriting discounts

    —



    1,017,074

    Payments of third-party IPO issuance costs

    —



    (3,407)

    Repurchase of shares

    —



    (844)

    Proceeds from issuance of common stock from employee equity plans

    25,779



    1,683

    Proceeds from issuances of debt, net of creditor fees

    390,140



    576,060

    Payments on debt

    (152,440)



    (1,584,080)

    Third-party fees paid in connection with issuance of new debt

    (42)



    (1,410)

    Finance lease liabilities paid

    (13,032)



    (821)

    Net cash provided by (used in) financing activities

    243,450



    16,654

    Increase/(decrease) in cash and cash equivalents during the period

    (127,773)



    159,154

    Cash and cash equivalents and restricted cash–beginning of period

    204,582



    45,428

    Cash and cash equivalents and restricted cash–end of period

    $       76,809



    $      204,582

    Supplemental disclosures of cash flow information







    Interest paid

    $        81,666



    $       122,771

    Cash taxes paid (refunds received), net

    32,418



    51,100

    Non-cash investing and financing activities







    Fixed asset purchases in accounts payable

    280



    283

    Unpaid third-party IPO issuance costs

    —



    15

    Common stock issued in connection to acquisitions (see Note 7)

    620,835



    —

    Reconciliation of Balance Sheet Cash Accounts to Cash Flow Statement







    Balance sheet







    Cash and cash equivalents

    61,355



    182,133

    Restricted cash

    15,454



    22,449

    Total

    76,809



    204,582

     

    Waystar

    Reconciliation of Adjusted EBITDA

    (in thousands) 

    (unaudited)















    Three months ended

    December 31,



    Twelve months ended

    December 31,

    ($ in thousands)



    2025



    2024



    2025



    2024

    Net income/(loss)



    $ 19,988



    $ 19,079



    $ 112,089



    $ (19,125)

    Interest expense



    22,872



    20,086



    77,542



    146,270

    Income tax expense/(benefit)



    16,158



    13,978



    59,674



    (3,420)

    Depreciation and amortization



    40,442



    37,996



    140,548



    186,631

    Stock-based compensation expense



    12,198



    7,037



    42,069



    54,437

    Acquisition and integration costs



    14,877



    163



    21,074



    859

    Costs related to amended debt agreements



    1,931



    1,262



    2,580



    14,138

    IPO related and Secondary Offering expenses



    86



    26



    4,657



    2,140

    Other (a)



    593



    526



    1,913



    1,566

    Adjusted EBITDA



    $ 129,145



    $ 100,153



    $ 462,146



    $ 383,496

    Revenue



    $ 303,538



    $ 244,102



    $ 1,099,278



    $ 943,549

    Net income/(loss) margin



    6.6 %



    7.8 %



    10.2 %



    (2.0) %

    Adjusted EBITDA margin



    42.5 %



    41.0 %



    42.0 %



    40.6 %





    (a)

    Adjustments relate to additional lease costs due to the relocation of our Louisville office totaling $0.6 million and $1.3 million, respectively, and executive severance totaling $0.0 million and $0.6 million, respectively, for the three and twelve months ended December 31, 2025. For the three and twelve months ended December 31, 2024, adjustments relate to additional lease costs due to the relocation of our Louisville office.

     

    Waystar

    Reconciliation of Non-GAAP Operating Expenses

    (in thousands)

    (unaudited)











    Three months ended

    December 31,



    Twelve months ended

    December 31,



    2025



    2024



    2025



    2024

    Cost of revenue (exclusive of depreciation and amortization expenses)

    92,637



    79,542



    348,162



    315,730

    Less Stock-based compensation expense

    (450)



    (242)



    (1,514)



    (2,403)

    Less Acquisition and integration costs

    (1,771)



    -



    (1,774)



    (31)

    Less IPO and Secondary Offering expenses

    -



    -



    -



    (9)

    Less Other (a)

    -



    (33)



    -



    (33)

    Cost of revenue (exclusive of depreciation and amortization expenses), adjusted

    90,416



    79,267



    344,874



    313,254

















    Sales and marketing

    49,212



    38,990



    178,017



    156,935

    Less Stock-based compensation expense

    (2,364)



    (1,482)



    (8,562)



    (12,440)

    Less Acquisition and integration costs

    (1,131)



    -



    (1,210)



    -

    Less IPO and Secondary Offering expenses

    -



    (7)



    -



    (148)

    Sales and marketing, adjusted

    45,717



    37,501



    168,245



    144,347

















    General and administrative

    43,709



    22,959



    128,623



    111,753

    Less Stock-based compensation expense

    (7,260)



    (4,245)



    (25,678)



    (31,288)

    Less Acquisition and integration costs

    (11,338)



    (157)



    (17,116)



    (429)

    Less Costs related to amended debt agreements

    (1,931)



    (1,262)



    (2,580)



    (14,138)

    Less IPO and Secondary Offering expenses

    (86)



    (19)



    (4,657)



    (1,975)

    Less Other (a)

    (593)



    (493)



    (1,913)



    (1,533)

    General and administrative, adjusted

    22,501



    16,783



    76,679



    62,390

















    Research and development

    18,520



    11,472



    54,623



    48,775

    Less Stock-based compensation expense

    (2,124)



    (1,068)



    (6,315)



    (8,306)

    Less Acquisition and integration costs

    (637)



    (6)



    (974)



    (399)

    Less IPO and Secondary Offering expenses

    -



    -



    -



    (8)

    Research and development, adjusted

    15,759



    10,398



    47,334



    40,062

















    Depreciation and amortization

    40,442



    37,996



    140,548



    186,631

    Less Other (a)

    -



    (2,103)



    -



    (17,879)

    Less Intangible amortization

    (34,528)



    (30,647)



    (118,609)



    (147,887)

    Depreciation and amortization, adjusted

    5,914



    5,246



    21,939



    20,865

















    Income tax expense/(benefit)

    16,158



    13,978



    59,674



    (3,420)

    Plus Tax effect of adjustments

    13,485



    8,770



    40,089



    50,170

    Income tax expense/(benefit), adjusted

    29,643



    22,748



    99,763



    46,750





    (a)

    Adjustments relate to additional lease costs due to the relocation of our Louisville office totaling $0.6 million and $1.3 million, respectively, and executive severance totaling $0.0 million and $0.6 million, respectively, for the three and twelve months ended December 31, 2025. For the three and twelve months ended December 31, 2024, adjustments relate to additional lease costs due to the relocation of our Louisville office.

     

    Waystar

    Reconciliation of Non-GAAP Net Income 

    (in thousands, except share and per share amounts)

    (unaudited)















    Three months ended

    December 31,



    Twelve months ended

    December 31,

    ($ in thousands)



    2025



    2024



    2025



    2024

    Net income/(loss)



    $    19,988



    $    19,079



    $    112,089



    $    (19,125)

    Stock based compensation



    12,198



    7,037



    42,069



    54,437

    Acquisition and integration costs



    14,877



    163



    21,074



    859

    Costs related to amended debt agreements



    1,931



    1,262



    2,580



    14,138

    IPO and Secondary Offering expenses



    86



    26



    4,657



    2,140

    Other (a)



    593



    2,629



    1,913



    19,445

    Intangible amortization



    34,528



    30,647



    118,609



    147,887

    Tax effect of adjustments



    (13,485)



    (8,770)



    (40,089)



    (50,170)

    Non-GAAP net income/(loss)



    $    70,716



    $    52,073



    $   262,902



    $    169,611



















    Non-GAAP net income/(loss) per share:

















    Basic



    $      0.37



    $      0.30



    $      1.48



    $       1.13

    Diluted



    $      0.36



    $      0.29



    $      1.42



    $      1.09

    Weighted-average shares outstanding:

















    Basic



    191,394,748



    172,526,776



    177,926,745



    149,915,839

    Diluted



    197,336,164



    179,112,559



    184,783,285



    155,677,094





    (a)

    Adjustments relate to additional lease costs due to the relocation of our Louisville office totaling $0.6 million and $1.3 million, respectively, and executive severance totaling $0.0 million and $0.6 million, respectively, for the three and twelve months ended December 31, 2025. For the three and twelve months ended December 31, 2024, adjustments relate to additional lease costs of $0.5 million and $1.6 million, respectively, and accelerated depreciation of $2.1 million and $17.9 million, respectively, due to the relocation of our Louisville office.

     

    Waystar

    Reconciliation of Unlevered Free Cash Flow

    (in thousands)

    (unaudited)









    Three months ended

    December 31,

    Twelve months ended

    December 31,



    2025



    2024

    2025



    2024

    Net cash provided by operating activities

    66,631



    64,770

    309,673



    169,768

    Interest paid

    22,363



    21,582

    81,666



    122,771

    Purchase of PP&E and capitalization of internally developed software costs

    (9,411)



    (6,224)

    (26,481)



    (27,268)

    Unlevered free cash flow

    79,583



    80,128

    364,858



    265,271

     

    Waystar

    Reconciliation of Net Debt

    (in thousands)

    (unaudited)







    December 31,



    2025



    2024

    First lien term loan facility outstanding debt, current

    14,194



    11,668

    First lien term loan facility outstanding debt, net of current portion

    1,387,052



    1,151,878

    Receivables facility outstanding debt

    80,000



    80,000

    Cash and cash equivalents

    (61,355)



    (182,133)

    Investment securities

    (24,877)



    -

    Net debt

    1,395,014



    1,061,413









    Trailing Twelve Months Adjusted EBITDA

    462,146



    383,496









    Adjusted Gross leverage ratio

    3.2x



    3.2x

    Adjusted Net leverage ratio

    3.0x



    2.8x

     

    Waystar

    Reconciliation of Trailing Twelve Months (TTM) Adjusted EBITDA

    (in thousands)

    (unaudited)











    Three Months Ended



    TTM



    December 31,

    2025



    September 30,

    2025



    June 30,

    2025



    March 31,

    2025



    December 31,

    2025

    Net income/(loss)

    19,988



    30,648



    32,184



    29,269



    112,089

    Interest expense

    22,872



    17,515



    18,255



    18,900



    77,542

    Income tax expense/(benefit)

    16,158



    12,069



    14,407



    17,040



    59,674

    Depreciation and amortization

    40,442



    33,300



    33,426



    33,380



    140,548

    Stock-based compensation expense

    12,198



    11,597



    11,530



    6,744



    42,069

    Acquisition and integration costs

    14,877



    5,313



    655



    229



    21,074

    Costs related to amended debt agreements

    1,931



    649



    -



    -



    2,580

    IPO and Secondary Offering expenses

    86



    1,372



    1,769



    1,430



    4,657

    Other (a)

    593



    240



    326



    754



    1,913

    Adjusted EBITDA

    129,145



    112,703



    112,552



    107,746



    462,146





    (a)

    Adjustments relate to additional lease costs due to the relocation of our Louisville office of $1.3 million, and executive severance $0.6 million, for the twelve months ended December 31, 2025.

     

    Media Contact

    Kristin Lee

    [email protected]

    Investor Contact

    [email protected]

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/waystar-reports-fourth-quarter-and-fiscal-year-2025-results-provides-2026-guidance-302689036.html

    SOURCE Waystar

    Get the next $WAY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $WAY

    DatePrice TargetRatingAnalyst
    2/2/2026$43.00Outperform
    Leerink Partners
    1/9/2026$41.00Overweight
    Wells Fargo
    12/15/2025$41.00Buy
    UBS
    11/13/2025$47.00Outperform
    BMO Capital Markets
    11/11/2025$46.00Buy
    Needham
    10/14/2025$50.00Overweight
    Barclays
    9/18/2025$48.00Mkt Outperform
    Citizens JMP
    9/5/2025$44.00Outperform
    Robert W. Baird
    More analyst ratings

    $WAY
    SEC Filings

    View All

    SEC Form 10-K filed by Waystar Holding Corp.

    10-K - Waystar Holding Corp. (0001990354) (Filer)

    2/17/26 6:49:32 AM ET
    $WAY
    EDP Services
    Technology

    Waystar Holding Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Waystar Holding Corp. (0001990354) (Filer)

    2/17/26 6:47:19 AM ET
    $WAY
    EDP Services
    Technology

    SEC Form 8-K filed by Waystar Holding Corp.

    8-K - Waystar Holding Corp. (0001990354) (Filer)

    2/6/26 4:06:08 PM ET
    $WAY
    EDP Services
    Technology

    $WAY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Waystar Advances AI Innovation with Google Cloud to Accelerate the Autonomous Revenue Cycle

    Waystar AltitudeAI unites proprietary financial and clinical data with generative and agentic AI embedded directly into revenue cycle workflows Expanded Google Cloud collaboration extends Waystar innovation through hyperscale infrastructure and Gemini large language models LEHI, Utah and LOUISVILLE, Ky., March 5, 2026 /PRNewswire/ -- Waystar (NASDAQ:WAY), a provider of leading healthcare payment software, today announced an expanded collaboration with Google Cloud to accelerate its agentic AI capabilities and advance the industry toward an autonomous revenue cycle. Waystar deliv

    3/5/26 9:05:00 AM ET
    $WAY
    EDP Services
    Technology

    Waystar AI Delivers Industry-Leading Outcomes, Earns #1 Client Ranking

    Black Book survey of more than 750 healthcare leaders demonstrates that Waystar leads the industry in client satisfaction with AI execution and outcomesLEHI, Utah, and LOUISVILLE, Ky., Feb. 20, 2026 /PRNewswire/ -- Waystar (NASDAQ:WAY), a provider of leading healthcare payment software, today announced that its AI capabilities earned the top ranking in the revenue cycle management industry, according to an independent survey by Black Book Market Research™ focused on agentic and generative AI in revenue cycle management. Waystar earned the top overall ranking across client-report

    2/20/26 9:00:00 AM ET
    $WAY
    EDP Services
    Technology

    Waystar Reports Fourth Quarter and Fiscal Year 2025 Results, Provides 2026 Guidance

    Q4 revenue of $304M, up 24% YoYQ4 net income of $20.0M and non-GAAP net income of $70.7M Q4 net income margin of 7%; adjusted EBITDA margin of 43%FY 2025 revenue of $1,099M, up 17% YoYFY net income of $112.1M and non-GAAP net income of $262.9M FY net income margin of 10%; adjusted EBITDA margin of 42% LEHI, Utah and LOUISVILLE, Ky., Feb. 17, 2026 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, today reported results for the fourth quarter and full year ended December 31, 2025. "Waystar is delivering strong growth and momentu

    2/17/26 7:00:00 AM ET
    $WAY
    EDP Services
    Technology

    $WAY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Miller Heidi bought $188,986 worth of shares (7,200 units at $26.25) (SEC Form 4)

    4 - Waystar Holding Corp. (0001990354) (Issuer)

    3/3/26 4:12:16 PM ET
    $WAY
    EDP Services
    Technology

    Chief Business Officer Sinclair Iii Eric L. (Ric) sold $1,210,077 worth of shares (40,225 units at $30.08) and exercised 40,225 shares at a strike of $6.78 (SEC Form 4)

    4 - Waystar Holding Corp. (0001990354) (Issuer)

    1/22/26 4:14:18 PM ET
    $WAY
    EDP Services
    Technology

    Chief Business Officer Sinclair Iii Eric L. (Ric) exercised 9,701 shares at a strike of $4.14 and sold $318,396 worth of shares (9,701 units at $32.82) (SEC Form 4)

    4 - Waystar Holding Corp. (0001990354) (Issuer)

    12/23/25 11:32:11 AM ET
    $WAY
    EDP Services
    Technology

    $WAY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Miller Heidi bought $188,986 worth of shares (7,200 units at $26.25) (SEC Form 4)

    4 - Waystar Holding Corp. (0001990354) (Issuer)

    3/3/26 4:12:16 PM ET
    $WAY
    EDP Services
    Technology

    Chairperson Driscoll John Patrick was granted 8,695 shares and bought $129,000 worth of shares (6,000 units at $21.50), increasing direct ownership by 21% to 85,623 units (SEC Form 4)

    4 - Waystar Holding Corp. (0001990354) (Issuer)

    6/12/24 4:32:09 PM ET
    $WAY
    EDP Services
    Technology

    $WAY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Leerink Partners initiated coverage on Waystar Holding Corp. with a new price target

    Leerink Partners initiated coverage of Waystar Holding Corp. with a rating of Outperform and set a new price target of $43.00

    2/2/26 7:47:52 AM ET
    $WAY
    EDP Services
    Technology

    Wells Fargo initiated coverage on Waystar Holding Corp. with a new price target

    Wells Fargo initiated coverage of Waystar Holding Corp. with a rating of Overweight and set a new price target of $41.00

    1/9/26 9:08:27 AM ET
    $WAY
    EDP Services
    Technology

    UBS initiated coverage on Waystar Holding Corp. with a new price target

    UBS initiated coverage of Waystar Holding Corp. with a rating of Buy and set a new price target of $41.00

    12/15/25 10:02:44 AM ET
    $WAY
    EDP Services
    Technology

    $WAY
    Leadership Updates

    Live Leadership Updates

    View All

    RIS Rx Appoints John Driscoll as Chairman of the Board

    RIS Rx, a healthcare technology company focused on helping pharmaceutical manufacturers optimize the patient payment revenue cycle, today announced the appointment of John Driscoll as Chairman of the Board of Directors. A veteran healthcare executive and board leader, Mr. Driscoll's career spans operations, strategy, and transformational growth across payers, providers, and health-tech platforms. Most recently, he served as Executive Vice President and President, U.S. Healthcare at Walgreens Boots Alliance following its acquisition of CareCentrix. He led CareCentrix as CEO for nearly a decade, growing its care-at-home capabilities and positioning the company as a leader in post-acute and

    10/15/25 9:00:00 AM ET
    $WAY
    EDP Services
    Technology

    AppLovin, Robinhood Markets and Emcor Group Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, Sept. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 100, S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, September 22, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space. Uber Technologies Inc. (NYSE:UBER) will replace Charter Communications Inc. (NASD: CHTR) in the S&P 100. Charter Communications will remain in the S&P 500.AppLovin Corp. (NASD: APP), Robinhood Markets Inc. (NASD: H

    9/5/25 6:34:00 PM ET
    $ACHC
    $APP
    $BGS
    Medical Specialities
    Health Care
    Computer Software: Programming Data Processing
    Technology

    New AI Rollouts Signal Shift From Hype to Healthcare Reality

    USA News Group News CommentaryIssued on behalf of Avant Technologies Inc. VANCOUVER, BC, June 24, 2025 /PRNewswire/ -- With populations again, and chronic diseases on the rise, global healthcare systems are facing enormous challenges ahead. However, there is hope on the horizon to alleviate some of these burdens, coming from the rise of AI in healthcare, as the new tech is proving it can improve diagnostic accuracies, drug discoveries, and administration work flow. Healthcare leaders are already reporting benefits, including reduced clinician workloads through voice-based AI tools and the use of AI agents to boost efficiency and support smarter care delivery. Behind the scenes, the tech is b

    6/24/25 9:45:00 AM ET
    $LLY
    $PHG
    $PLTR
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical Electronics
    Computer Software: Prepackaged Software

    $WAY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Waystar Holding Corp.

    SC 13G - Waystar Holding Corp. (0001990354) (Subject)

    11/14/24 5:30:28 PM ET
    $WAY
    EDP Services
    Technology

    SEC Form SC 13G filed by Waystar Holding Corp.

    SC 13G - Waystar Holding Corp. (0001990354) (Subject)

    11/14/24 6:00:14 AM ET
    $WAY
    EDP Services
    Technology

    SEC Form SC 13G filed by Waystar Holding Corp.

    SC 13G - Waystar Holding Corp. (0001990354) (Subject)

    11/8/24 4:30:50 PM ET
    $WAY
    EDP Services
    Technology

    $WAY
    Financials

    Live finance-specific insights

    View All

    Waystar Reports Fourth Quarter and Fiscal Year 2025 Results, Provides 2026 Guidance

    Q4 revenue of $304M, up 24% YoYQ4 net income of $20.0M and non-GAAP net income of $70.7M Q4 net income margin of 7%; adjusted EBITDA margin of 43%FY 2025 revenue of $1,099M, up 17% YoYFY net income of $112.1M and non-GAAP net income of $262.9M FY net income margin of 10%; adjusted EBITDA margin of 42% LEHI, Utah and LOUISVILLE, Ky., Feb. 17, 2026 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, today reported results for the fourth quarter and full year ended December 31, 2025. "Waystar is delivering strong growth and momentu

    2/17/26 7:00:00 AM ET
    $WAY
    EDP Services
    Technology

    Waystar to Announce Fourth Quarter and Fiscal Year 2025 Financial Results on February 17, 2026

    LEHI, Utah, and LOUISVILLE, Ky., Feb. 3, 2026 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, announced today that it will report financial results for the fourth quarter and fiscal year ended December 31, 2025, before market open on Tuesday, February 17, 2026. The company will discuss its financial results on a conference call at 8:30 a.m. Eastern Time that same day. A live audio webcast of the conference call will be available on Waystar's investor relations website at https://investors.waystar.com/news-events/events. Th

    2/3/26 8:30:00 AM ET
    $WAY
    EDP Services
    Technology

    Waystar Reports Third Quarter 2025 Results

    Q3 revenue growth of 12% year-over-year Q3 net income of $30.6 million and non-GAAP net income of $67.8 million Q3 net income margin of 11%; adjusted EBITDA margin of 42% Raising revenue and adjusted EBITDA guidance for 2025 LEHI, Utah and LOUISVILLE, Ky., Oct. 29, 2025 /PRNewswire/ -- Waystar Holding Corp. (NASDAQ:WAY), a provider of leading healthcare payment software, today reported results for the third quarter ended September 30, 2025. "Waystar delivered another quarter of double-digit revenue growth and strong margins, outpacing our guidance on both measures," said Mat

    10/29/25 4:05:00 PM ET
    $WAY
    EDP Services
    Technology